Gradient Capital Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.77M Sell
15,624
-4,983
-24% -$1.51M 1.57% 19
2026
Q1
$4.4M Sell
20,607
-750
-4% -$168K 1.14% 29
2025
Q4
$3.66M Sell
21,357
-578
-3% -$89.9K 0.94% 37
2025
Q3
$2.94M Sell
21,935
-485
-2% -$51.4K 0.79% 40
2025
Q2
$2.18M Buy
22,420
+846
+4% +$67.1K 0.64% 40
2025
Q1
$1.57M Sell
21,574
-1,309
-6% -$103K 0.51% 48
2024
Q4
$1.65M Sell
22,883
-27
-0.1% -$2.05K 0.53% 43
2024
Q3
$1.87M Sell
22,910
-1,400
-6% -$122K 0.62% 38
2024
Q2
$2.59M Sell
24,310
-400
-2% -$38.4K 0.93% 32
2024
Q1
$2.4M Sell
24,710
-1,670
-6% -$147K 0.88% 33
2023
Q4
$2.07M Buy
26,380
+50
+0.2% +$3.41K 0.79% 33
2023
Q3
$1.65M Buy
26,330
+40
+0.2% +$2.63K 0.69% 35
2023
Q2
$1.69M Buy
26,290
+230
+0.9% +$13K 0.68% 32
2023
Q1
$1.38M Buy
26,060
+790
+3% +$38.8K 0.59% 40
2022
Q4
$1.06M Buy
25,270
+70
+0.3% +$2.93K 0.48% 49
2022
Q3
$922K Buy
25,200
+1,250
+5% +$55.6K 0.44% 56
2022
Q2
$1.02M Sell
23,950
-660
-3% -$31.4K 0.49% 52
2022
Q1
$1.32M Sell
24,610
-730
-3% -$42.5K 0.56% 45
2021
Q4
$1.82M Buy
25,340
+1,150
+5% +$72.1K 0.76% 32
2021
Q3
$1.38M Buy
24,190
+40
+0.2% +$2.43K 0.63% 37
2021
Q2
$1.57M Buy
24,150
+140
+0.6% +$8.84K 0.74% 33
2021
Q1
$1.43M Buy
24,010
+140
+0.6% +$7.63K 0.76% 31
2020
Q4
$1.13M Sell
23,870
-6,220
-21% -$262K 0.64% 37
2020
Q3
$998K Buy
30,090
+3,870
+15% +$133K 0.62% 39
2020
Q2
$848K Buy
26,220
+1,190
+5% +$32.5K 0.57% 42
2020
Q1
$601K Buy
25,030
+3,440
+16% +$99K 0.49% 48
2019
Q4
$631K Sell
21,590
-1,750
-7% -$46.5K 0.44% 51
2019
Q3
$539K Buy
23,340
+1,250
+6% +$26.2K 0.4% 57
2019
Q2
$415K Buy
22,090
+120
+0.5% +$2.28K 0.32% 60
2019
Q1
$393K Buy
21,970
+1,510
+7% +$25.2K 0.31% 60
2018
Q4
$279K Buy
20,460
+430
+2% +$6.16K 0.24% 70
2018
Q3
$304K Sell
20,030
-1,360
-6% -$23.2K 0.26% 73
2018
Q2
$370K Buy
+21,390
New +$412K 0.34% 60

Other funds holding LRCX

Gradient Capital Advisors's LRCX Position: Q2 2026 in Review

Gradient Capital Advisors reduced its Lam Research (LRCX) stake by 24% in Q2 2026, selling an estimated $1.51M and leaving 15,624 shares worth $6.77M. The position accounts for 1.57% of the portfolio, ranked #19.

Gradient Capital Advisors first reported a position in LRCX in Q2 2018 and has held it in 33 quarters since. 535 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Gradient Capital Advisors held 15,624 shares of Lam Research worth $6.77M as of Q2 2026.
  • Gradient Capital Advisors sold 4,983 Lam Research shares in Q2 2026, an estimated $1.51M.
  • Lam Research made up 1.57% of Gradient Capital Advisors's portfolio in Q2 2026, its #19 holding.
  • Gradient Capital Advisors first reported a position in Lam Research in Q2 2018 and has held it in 33 quarters since.
  • 535 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.